• Molecular NameMitiglinide
  • SynonymKAD-1229; mitiglinide; Mitiglinide calcium hydrate
  • Weight315.413
  • Drugbank_IDDB01252
  • ACS_NO207844-01-7
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)3.3
  • pkaN/A
  • LogD (pH=7, predicted)0.7
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.62
  • LogSw (predicted, AB/LogsW2.0)0.04
  • Sw (mg/ml) (predicted, ACD/Labs)0.03
  • No.of HBond Donors1
  • No.of HBond Acceptors4
  • No.of Rotatable Bonds5
  • TPSA57.61
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA drug for the treatment of type 2 diabetes.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A